# Nigeria vaccine manufacturing and accessibility efforts > Live situation record from CLSTR: https://clstr.news/situations/nigeria-vaccine-manufacturing-and-accessibility-efforts > Updated: 2026-10-04T14:10:28.000Z. Sources: 6. Developments: 2. Efforts to improve vaccine accessibility and manufacturing capacity have gained focus in Nigeria. Public health initiatives are addressing the need for local production to reduce dependence on imports and enhance health security. Prof. Mojisola Adeyeye, Director-General of Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC), has called for international support to establish local vaccine manufacturing facilities, specifically requesting contributions for fill-and-finish modular plants. Adeyeye noted that while NAFDAC has met eight of the nine required functions for World Health Organization (WHO) Maturity Level 4 benchmarking in medicines and vaccines, the lack of local manufacturing capacity is the final requirement for attaining this status. She emphasized that returning to local production is critical for national security and commended recent executive incentives provided to local manufacturers. ## Timeline ### 2026-10-04: Nigeria seeks international support for local vaccine production NAFDAC Director General Prof. Mojisola Adeyeye is calling for international support to establish local vaccine manufacturing in Nigeria to achieve WHO Maturity Level 4 status. 4 sources. https://clstr.news/cluster/nigeria-seeks-international-support-for-local-vaccine-production ### 2026-10-03: Global efforts focus on vaccine manufacturing and disease tracking New health initiatives aim to improve vaccine security and monitoring, including a U.S. disease tracker and calls for local vaccine manufacturing in Nigeria to reduce import dependency. 2 sources. https://clstr.news/cluster/global-efforts-focus-on-vaccine-manufacturing-and-disease-tracking --- Cite as: Nigeria vaccine manufacturing and accessibility efforts. CLSTR, https://clstr.news/situations/nigeria-vaccine-manufacturing-and-accessibility-efforts